2020 (modified: 04 Nov 2022)ICML 2020Readers: Everyone
Abstract:Phase I dose-finding trials are increasingly challenging as the relationship between efficacy and toxicity of new compounds (or combination of them) becomes more complex. Despite this, most commonl...